hVIVO plc (formerly Open Orphan plc)
Company Profile
Company website
Sector
Health Care Providers (Health Care Services)
Description
hVIVO plc (ticker: HVO) (formerly Open Orphan plc) is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. The Group provides end-to-end early clinical development services to its large, established and growing repeat client base, which includes four of the top 10 largest global biopharma companies.
---two-page-company-summary-(march-2024).png "hVIVO (AIM HVO) - Two page Company summary (March 2024)")
Investor Access
13
May
Event information
The Company’s AGM will be held at the offices of DAC Beachcroft LLP, 25 Walbrook, London EC4N 8AF, United Kingdom on 13 May 2024 at 11am (BST)
The 2023 Annual Report and Accounts, the Notice of AGM and accompanying form of proxy are available to download from the Company’s website www.hvivo.com.Venue
At the offices of DAC Beachcroft LLP, 25 Walbrook, London EC4N 8AF, United Kingdom
Time
Monday 13 May 2024 at 11am (BST)
Financial Calendar
| Event | Date |
| Year End | 31 December |
| Half Year End | 30 June |
| Preliminary Results* | April |
| Interim Results* | September |
| AGM* | May |
* Months based on previous announcements of this kind
